Genmab A (GMAB) Shares Outstanding (Weighted Average) (2023 - 2025)

Genmab A's Shares Outstanding (Weighted Average) history spans 3 years, with the latest figure at $64.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 547.21% year-over-year to $64.7 million; the TTM value through Dec 2025 reached $64.7 million, up 547.21%, while the annual FY2025 figure was $64.7 million, 547.21% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $64.7 million in Q4 2025 per GMAB's latest filing, up from $10.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $66.1 million in Q4 2023 to a low of $10.0 million in Q4 2024.
  • Average Shares Outstanding (Weighted Average) over 3 years is $46.9 million, with a median of $64.7 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Weighted Average): crashed 84.87% in 2024, then soared 547.21% in 2025.
  • A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $66.1 million in 2023, then plummeted by 84.87% to $10.0 million in 2024, then skyrocketed by 547.21% to $64.7 million in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Shares Outstanding (Weighted Average) are $64.7 million (Q4 2025), $10.0 million (Q4 2024), and $66.1 million (Q4 2023).